Various pathways, including MAPK, Janus kinase (JAK)/signal transducer and activator of transcription (STAT), nuclear factor-κB (NF-κB), Wnt, and Hh signaling pathways have been shown to affect the signaling of PD-1/PD-L1 in tumor cells [50]. This evidence concerns the gene PDCD1 and neoplasm.